Engineered Resilience
  • Get Involved ▾
    For Doers For Funders
    The Studio
  • Microplastics TrendspotterBETA
  • Newsletter
  • About
  • Contact Us
← Back to newsletters

January 2026 Dispatch

From metabolic fingerprints to active elimination—biotech is used to catch mechanisms and counteract pollutant exposures.

Also on Substack

January 2026 Dispatch

Summary: 13 articles | Bench: 4 | Translation: 4 | Policy: 2 | Defense: 3

Exposures & Mechanisms

[Bench] Micro/nanoplastics (MNP) intensify gut inflammation by flipping macrophage behavior (Medical Xpress)
- MNPs accumulate in gut and other organs under inflammatory conditions
- MNPs in the gut activate macrophages and disrupt the microbiome. Both responses are potential druggable intervention points

[Bench] Chlorpyrifos more than doubles Parkinson's risk via autophagy disruption (UCLA Health)
- The pesticide chlorpyrifos is associated with "an almost 3-fold risk of developing Parkinson's disease"
- Study showed causal link in zebrafish—pesticide prevents brain cells from metaphorically "taking out the trash." How could we recover the cellular clean-up mechanism as a target for intervention?

[Bench] 100% of children 0-2 show metal mixtures in hair; arsenic most neurotoxic (Medical Xpress)
- Chemical mixtures are the unit of harm and hair samples offer new biomarkers
- The 6-month vulnerability window defines where early intervention could prevent the most damage


Early Detection & Biomarkers

[Translation] Air pollution metabolic signatures predict cardiovascular events (PubMed)
- Pollution leaves metabolic fingerprints (choline, glycerol) that predict cardiovascular events
- These signatures are candidate biomarkers—catching exposure-driven disease in molecular infancy

[Translation] Blood test flags Parkinson's years before symptoms via DNA repair signature (ScienceDaily)
- A distinct pattern of gene activity related to DNA repair and stress response was found in early phase of Parkinson's disease
- This damage could perhaps also be detected after an environmental exposure, and then reversed to prevent the disease state

[Translation] Alzheimer's biomarkers from finger-prick blood samples mailed from home (Banner Health)
- "Finger-prick blood samples mailed from home detect Alzheimer's biomarkers (p-tau217, GFAP, NfL) with 86% accuracy"
- Large-scale screening could reach underserved populations in medical deserts and expand to early markers of disease due to exposure to pollutants


AI & Biotech Platforms

[Bench] Arc + Tahoe + Biohub build 120M-cell perturbation dataset (Biohub)
- The largest perturbation dataset fuels virtual cell models
- Including environmental toxicants would enable prediction of exposure responses and generalization of these models

[Translation] ARPA-H launches BIOGAMI to detect early protein dysfunction (ARPA-H)
- Targeting protein misfolding before neurodegeneration is the pre-disease intervention paradigm applied to proteostasis—catch it early, before damage accumulates


Chemical Policy

[Policy] FDA: 50+ PFAS ingredients in 1,700 personal care products (EWG)
- Intentional PFAS addition with no toxicological data exemplifies the regulatory gap
- These exposures need both regulatory reform and active biotech solutions for elimination

[Policy] Delaware secures $25M PFAS settlement for health surveillance (Delaware News)
- Large settlement fund flowing to research on health surveillance in PFAS-exposed population
- Could this model of diverting capital ultimately fund more early interventions at-scale?


Active Clearance & Protection

[Defense] Cholestyramine accelerates PFAS clearance 20-fold (ACS Central Science)
- Active clearance in action: a repurposed cholesterol drug binds PFAS in gut and accelerates excretion
- Engineering elimination of "forever chemicals" reduces body burden

[Defense] Methionine boosts kidney filtration, clears inflammatory molecules (Salk Institute)
- Dietary methionine enhancing kidney filtration demonstrates we can tune elimination machinery
- This principle can extend to toxicant clearance through enhanced excretion

[Defense] Tulip Biosciences develops mucus barrier therapeutics from MIT research (LinkedIn)
- Tulip's platform targets barrier breakdown across mucosal surfaces
- Mucosal surfaces could be optimized to protect as a first line of defense against pollutant exposures


The Engineered Resilience Dispatch has been curated for you using carefully managed scripts with a human-in-the-loop. If we've missed a point or if you have recommendations of topics/groups to follow, we'd love to hear it. Contact Us

Engineered Resilience

Turning decades of research on pollutants into biotech interventions that protect human health.

Get Involved

  • For Doers
  • For Funders
  • Newsletter

Learn More

  • About
  • Microplastics TrendspotterBETA
  • Contact Us

Join the Conversation

Subscribe to Substack for progress updates and the latest biotech breakthroughs, clinical developments, policy changes, and defense applications towards engineered resilience.

Check your email to confirm your subscription.

Homeworld Collective

This work was developed at Homeworld Collective, a 501(c)(3) organization dedicated to nurturing the growth of biotech to solve planetary-scale challenges.

© 2026 Engineered Resilience. All rights reserved. · Privacy Policy